SCHEMBL13637278

SCHEMBL13637278

O=C(O)COc1ccc(OCCCOc2ccc(-c3ccoc3)cc2-n2nc3ccccc3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 6/20 0.47
PPARA Q07869 5/20 0.47
PPARG P37231 5/20 0.47
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 3/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MAPT P10636 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
POLB P06746 1/20 0.41
ACACA Q13085 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3593824 0.81 PPARG (0.51) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13637196 0.81 KDM4E (0.53) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13440569 0.81 KDM4E (0.51) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13637276 0.80 PPARG (0.46) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13637273 0.80 PPARD (0.48) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13440568 0.79 KDM4E (0.52) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13441819 0.76 KDM4E (0.50) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13637161 0.76 PPARD (0.42) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL13637277 0.76 KDM4E (0.46) PPARDPPARAPPARGALDH1A1KDM4E
SCHEMBL3587102 0.75 TDP1 (0.49) PPARDPPARAPPARGALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 US disclosed